US 9174964
AMPK-activating piperidinyloxy-substituted 2,3-dihydro-1H-indene-1-amine compounds and pharmaceutical compositions including the same
granted A61PA61P3/00A61P3/06
Quick answer
US patent 9174964 (AMPK-activating piperidinyloxy-substituted 2,3-dihydro-1H-indene-1-amine compounds and pharmaceutical compositions including the same) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P3/00, A61P3/06, A61P3/08, A61P3/10